Poster Abstract Session:
64. Pediatric HIV
Thursday, October 8, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: HIV-STD-TB, Pediatric ID

Presentations:
466
Persistence of HIV Drug Resistance among South African Children Exposed to Nevirapine Prophylaxis for prevention of Mother-to-Child-Transmission (pMTCT)
Ruth Kanthula, MD, MPH ; Ingrid Beck, MS ; Gisela Van Dyk, M.S. ; Rachel Silverman, M.S. ; Scott Olson, MD ; Christen Salyer, B.S. ; Sharon Cassol, PhD ; Theresa Rossouw, MBChB, MPhil, MPH, PhD ; Lisa Frenkel, MD, FIDSA
467
Ethnicity Associated Disparities in Antiretroviral Resistance among Perinatally HIV Infected Children and Adolescents
German Contreras, MD MSc ; Cynthia Bell, MS ; Gabriela Delbianco, MD ; Norma Perez, DO ; Matthew Kleinosky, BS ; Laura Benjamins, MD ; James R. Murphy, PhD ; Gloria P. Heresi, MD
Posters
  • poster_IDSA_2015.pdf (480.2 kB)
  • 468
    Long-Term Safety and Efficacy of Dolutegravir in HIV Treatment-Experienced Adolescents
    Rolando Viani, MD ; Carmelita Alvero, MS ; Terence Fenton, PhD ; Edward Acosta, Pharm.D ; Rohan Hazra, M.D. ; Ellen Townley, FNP ; Paul Palumbo, MD ; Debra Steimers, MS ; Ann Buchanan, MD ; Cindy Vavro, PhD ; Andrew Wiznia, MD
    469
    Neurocognitive Dysfunction in HIV-Infected Youth: Investigating the Relationship to Immune Activation
    Julia Rosebush, DO ; Ann Chahroudi, MD, PhD ; Seungeun Lee, BS ; Mary Ann O'Riordan, MS, PhD ; Chanda Graves, PhD ; Anita Grover, PsyD ; Ashley Alexander, PsyD ; Bridget Wynn, BS ; Grace McComsey, MD ; Allison R. Eckard, MD
    Posters
  • NC_IDWeek_poster2015.pdf (1.6 MB)
  • 471
    Pediatric HIV Cure: a Rhesus Macaque Model
    Maud Mavigner, PhD ; Jakob Habib, BA ; Emily Cartwright, BA ; Benton Lawson, MS ; Mirko Paiardini, PhD ; Joyce Cohen, VMD, DACLAM ; Franck Amblard, PhD ; Raymond Schinazi, PhD, DSc ; Romas Geleziunas, PhD ; Joseph Hesselgesser, PhD ; Bei Li, PhD ; Jillian Hattersley, PhD ; Guido Silvestri, MD ; Ann Chahroudi, MD, PhD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.